Eyenuk, Inc. Expands into Germany with Launch of EyeArt® Artificial Intelligence Eye Screening for Diabetic Retinopathy

CE_logo_nemko_EyeArt_resized

LOS ANGELES, California, Oct. 2, 2018 – Eyenuk, Inc. announces its expansion into Germany with the adoption of EyeArt® artificial intelligence (AI) technology for the screening of diabetic retinopathy at Diabetes Center Mergentheim in Bad Mergentheim, Germany. The center is the first dedicated diabetic clinic in Germany to use artificial intelligence for screening of diabetic […]

Continue Reading »